Efficacy of Delayed Coloanal Anastomosis for Medium and Lower Rectum Cancer Treatment. Phase 2 Clinical Trial (CASCADOR)

NCT ID: NCT01876901

Last Updated: 2025-09-04

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE2

Total Enrollment

124 participants

Study Classification

INTERVENTIONAL

Study Start Date

2010-08-11

Study Completion Date

2019-02-14

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Hypothesis:

In France, approximately 12,000 new rectal cancers are diagnosed each year. Frequency is one and a half times higher in men than in women. The average age of diagnosis is 65. Unlike colon cancer, technical management remains challenging with unresolved operating difficulties. Morbidity of surgical procedures remains high with a very large number of preventive or curative stoma derivations.

Reference in surgical treatment is total excision of the rectum and its mesentery, followed by continuity restoration by immediate coloanal anastomosis (ACAI). In this procedure, rate of fistula that results is reported in the literature between 15 and 25%.

An alternative to ACAI is delayed coloanal anastomosis without reservoir (ACAD). Based on retrospective experiences, we form the hypothesis that ACAD offers a much lower rate of fistula (\<5%) and allows diminution of preventive stoma derivation practice. Morbidity and mortality are reduced, and patient's quality of life greatly improved. Direct costs (consumables intraoperative, hospitalization, stoma complications) and indirect (pocket-fitting stoma) are greatly reduced.

This study is a multicentre, two arms, phase 2 clinical trial.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Medium and Lower Rectal Cancer

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

PARALLEL

Two multicenter parallel single-arm phase II trials.

One trial assessing 2-stage pull-through colo-anal anastomosis without prophylactic derivation (2SCA) in centers who routinely performing this intervention.

One trial assessing colo-anal anastomosis (CAA) in centers who routinely performing this intervention.
Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

2-stage pull-through colo-anal anastomosis without prophylactic derivation (2SCA)

Patients treated with 2-stage pull-through colo-anal anastomosis without prophylactic derivation (2SCA) in centers who routinely performing this intervention.

Group Type EXPERIMENTAL

2-stage pull-through colo-anal anastomosis without prophylactic derivation (2SCA)

Intervention Type PROCEDURE

2-stage pull-through colo-anal anastomosis without prophylactic derivation (2SCA) Whatever the mode of continuity restoration used, resection is the same in the two groups. It consists of total excision of the rectum and its mesorectum, that intervention should be performed by laparotomy or laparoscopy.

After surgical resection, the colon is exteriorized through the anus and attached to the buttock.

By day 6, exteriorized colon is resected and coloanal anastomosis is performed without preventive stoma derivation

Colo-anal anastomosis (CAA)

Patients operated with colo-anal anastomosis (CAA) in centers who routinely performing this intervention.

Group Type EXPERIMENTAL

Colo-anal anastomosis (CAA)

Intervention Type PROCEDURE

After the surgical resection, coloanal anastomosis is performed usually after completion of a reservoir J when it is possible. Preventive ostomy is performed most often.

In the absence of fistula, the patient will reoperation for stoma closure of its branch

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

2-stage pull-through colo-anal anastomosis without prophylactic derivation (2SCA)

2-stage pull-through colo-anal anastomosis without prophylactic derivation (2SCA) Whatever the mode of continuity restoration used, resection is the same in the two groups. It consists of total excision of the rectum and its mesorectum, that intervention should be performed by laparotomy or laparoscopy.

After surgical resection, the colon is exteriorized through the anus and attached to the buttock.

By day 6, exteriorized colon is resected and coloanal anastomosis is performed without preventive stoma derivation

Intervention Type PROCEDURE

Colo-anal anastomosis (CAA)

After the surgical resection, coloanal anastomosis is performed usually after completion of a reservoir J when it is possible. Preventive ostomy is performed most often.

In the absence of fistula, the patient will reoperation for stoma closure of its branch

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Histologically proven rectal adenocarcinoma.
* Medium or lower rectum tumour requiring removal of the entire rectum and its mesorectum.
* T1 N+ or T2 N+ or T3 N+ or T3 N0 and M0 tumour.
* Age between 18 and 75 years .
* ASA ≤ 2.
* Sphincter continence compatible with coloanal anastomosis.
* Patients who received preoperative radiotherapy alone or chemotherapy and radiotherapy.
* Patient affiliated to social security.
* For patients of childbearing age, use of contraception.
* Patient information and consent for study participation

Exclusion Criteria

* Other histology of rectal cancer.
* T1 N0 or T2 N0 or T4 tumour.
* Metastatic disease M1.
* History of cancer except cervix in situ carcinoma or skin basal cell carcinoma.
* Patient with psychological, social, family or geographical reasons who couldn't be treated or monitored regularly by the criteria of the study
* Patients deprived of liberty or under guardianship.
* Pregnant or nursing women.
Minimum Eligible Age

18 Years

Maximum Eligible Age

75 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Institut Bergonié

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

EVRARD Serge, PU-PH

Role: STUDY_CHAIR

Institut Bergonié

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

CHU DE BORDEAUX - Hôpital Saint André

Bordeaux, Aquitaine, France

Site Status

Institut Bergonié

Bordeaux, Aquitaine, France

Site Status

CHU de GRENOBLE

Grenoble, Auvergne-Rhône-Alpes, France

Site Status

Centre Léon Bérard

Lyon, Auvergne-Rhône-Alpes, France

Site Status

HOSPICES CIVILS DE LYON - Hôpital de la Croix Rousse

Lyon, Auvergne-Rhône-Alpes, France

Site Status

Clinique Du Tonkin

Villeurbanne, Auvergne-Rhône-Alpes, France

Site Status

Institut Paoli Calmettes

Marseille, Bouche Du Rhône, France

Site Status

Chu de Nancy

Nancy, Lorraine, France

Site Status

Centre Alexis Vautrin

Vandœuvre-lès-Nancy, Lorraine, France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

References

Explore related publications, articles, or registry entries linked to this study.

Evrard S, Bellera C, Desolneux G, Cantarel C, Toulza E, Faucheron JL, Rivoire M, Dupre A, Mabrut JY, Bresler L, Marchal F, Bouriez D, Rullier E. Anastomotic leakage and functional outcomes following total mesorectal excision with delayed and immediate colo-anal anastomosis for rectal cancer: Two single-arm phase II trials. Eur J Surg Oncol. 2023 Nov;49(11):107015. doi: 10.1016/j.ejso.2023.107015. Epub 2023 Oct 23.

Reference Type BACKGROUND
PMID: 37949519 (View on PubMed)

Provided Documents

Download supplemental materials such as informed consent forms, study protocols, or participant manuals.

Document Type: Study Protocol and Statistical Analysis Plan

View Document

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

IB2010-08

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Safe Anastomosis Feasibility Study
NCT05180565 COMPLETED NA